{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T07:20:04Z","timestamp":1777706404826,"version":"3.51.4"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1991,1,1]],"date-time":"1991-01-01T00:00:00Z","timestamp":662688000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[1991]]},"DOI":"10.1007\/bf00856660","type":"journal-article","created":{"date-parts":[[2004,12,24]],"date-time":"2004-12-24T19:16:56Z","timestamp":1103915816000},"page":"639-649","source":"Crossref","is-referenced-by-count":21,"title":["Prostanoids in paediatric kidney diseases"],"prefix":"10.1007","volume":"5","author":[{"given":"Hannsj\ufffdrg W.","family":"Seyberth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Leonhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"T\ufffdnshoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nader","family":"Gordjani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/ki.1986.13","volume":"29","author":"D Schlondorff","year":"1986","unstructured":"Schlondorff D, Ardaillou R (1986) Prostaglandins and other arachidonic acid metabolites in the kidney. Kidney Int 29:108?119","journal-title":"Kidney Int"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0002-9343(86)90904-6","volume":"81","author":"R Ardaillou","year":"1986","unstructured":"Ardaillou R, Baud L, Sraer J (1986) Leukotrienes and other lipoxygenase products of arachidonic acid synthesized in the kidney. Am J Med 81:12?22","journal-title":"Am J Med"},{"key":"CR3","first-page":"229","volume":"40","author":"FA Fitzpatrick","year":"1989","unstructured":"Fitzpatrick FA, Murphy RC (1989) Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of ?epoxygenase?-derived eicosanoids. Pharmacol Rev 40:229?241","journal-title":"Pharmacol Rev"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/ki.1990.13","volume":"37","author":"ML Schwartzman","year":"1990","unstructured":"Schwartzman ML, Martasek P, Rios AR, Levere RD, Solangi K, Goodman AI, Abraham NG (1990) Cytochrome P450-dependent arachidonic acid metabolism in human kidney. Kidney Int 37:94?99","journal-title":"Kidney Int"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0090-6980(88)90089-5","volume":"35","author":"HW Seyberth","year":"1988","unstructured":"Seyberth HW, Tulassay T, K\u00fchl PG, Soeding K, Rascher W, Schweer H (1988) Excretion of primary prostanoids and their metabolites during acute volume expansion. Prostaglandins 35:221?232","journal-title":"Prostaglandins"},{"key":"CR6","first-page":"1155","volume":"251","author":"A Miyanoshita","year":"1989","unstructured":"Miyanoshita A, Terada M, Endou H (1989) Furosemide directly stimulates prostaglandin E2 production in the thick ascending limb of Henle's loop. J Pharmacol Exp Ther 251:1155?1159","journal-title":"J Pharmacol Exp Ther"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ki.1990.67","volume":"37","author":"C Zoja","year":"1990","unstructured":"Zoja C, Benigni A, Renzi D, Piccinelli A, Perico N, Remuzzi G (1990) Endothelin and eicosanoid synthesis in cultured mesangial cells. Kidney Int 37:927?933","journal-title":"Kidney Int"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00496408","volume":"147","author":"HW Seyberth","year":"1988","unstructured":"Seyberth HW, K\u00fchl PG (1988) The role of eicosanoids in pediatrics. Eur J Pediatr 147:341?349","journal-title":"Eur J Pediatr"},{"issue":"Suppl 1","key":"CR9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000186032","volume":"55","author":"JM Dunn","year":"1990","unstructured":"Dunn JM (1990) Prostaglandins, angiotensin II, and proteinuria. Nephron 55 [Suppl 1]:30?37","journal-title":"Nephron"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1987.164","volume":"32","author":"C Patrono","year":"1987","unstructured":"Patrono C, Dunn MJ (1987) The clinical significance of inhibition of renal prostaglandin synthesis. Kidney Int 32:1?12","journal-title":"Kidney Int"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/ki.1980.179","volume":"18","author":"MJ Dunn","year":"1980","unstructured":"Dunn MJ, Zambraski EJ (1980) Renal effects of drugs that inhibit prostaglandin synthesis. Kidney Int 18:609?622","journal-title":"Kidney Int"},{"issue":"Suppl 2B","key":"CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(86)90903-4","volume":"81","author":"D Schlondorff","year":"1986","unstructured":"Schlondorff D (1986) Renal prostaglandin synthesis. Am J Med 81 [Suppl 2B]:1?11","journal-title":"Am J Med"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ki.1989.211","volume":"36","author":"DA Molony","year":"1989","unstructured":"Molony DA, Reeves WB, Andreoli TE (1989) Na+:K+:2Cl-cotransport and the thick ascending limb. Kidney Int 36:418?426","journal-title":"Kidney Int"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1172\/JCI107987","volume":"55","author":"JC Fr\u00f6lich","year":"1975","unstructured":"Fr\u00f6lich JC, Wilson TW, Sweetman BJ, Smigel M, Nies AS, Carr K, Watson JT, Oates JA (1975) Urinary prostaglandins: identification and origin. J Clin Invest 55:763?766","journal-title":"J Clin Invest"},{"issue":"Suppl 2B","key":"CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9343(86)90905-8","volume":"81","author":"F Catella","year":"1986","unstructured":"Catella F, Nowak J, FitzGerald GA (1986) Measurement of renal and nonrenal eicosanoid synthesis. Am J Med 81 [Suppl 2B]:23?29","journal-title":"Am J Med"},{"key":"CR16","first-page":"87","volume":"15","author":"GA FitzGerald","year":"1985","unstructured":"FitzGerald GA, Lawson J, Blair IA, Brash AR (1985) Analysis of urinary metabolites of thromboxane and prostacyclin by negativeion chemical-ionization gas chromatography\/mass spectrometry. Adv Prostaglandin Thromboxane Leukotriene Res 15:87?90","journal-title":"Adv Prostaglandin Thromboxane Leukotriene Res"},{"key":"CR17","first-page":"337","volume-title":"Renal biochemistry. Cells, membranes, molecules","author":"D Schlondorff","year":"1985","unstructured":"Schlondorff D (1985) Prostaglandins and other arachidonate metabolites and the kidney. In: Kinne RKH (ed) Renal biochemistry. Cells, membranes, molecules. Elsevier, New York, pp 337?421"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00915791","volume":"3","author":"JS Goodwin","year":"1983","unstructured":"Goodwin JS, Ceuppens J (1983) Regulation of the immune response by prostaglandins. J Clin Immunol 3:295?315","journal-title":"J Clin Immunol"},{"key":"CR19","first-page":"72","volume":"38","author":"JA Oates","year":"1979","unstructured":"Oates JA, Whorton AR, Gerkens JF, Branch RA, Hollifield JW, Fr\u00f6lich JC (1979) The participation of prostaglandins in the control of renin release. Fed Proc 38:72?74","journal-title":"Fed Proc"},{"key":"CR20","first-page":"110","volume":"24","author":"G Remuzzi","year":"1987","unstructured":"Remuzzi G, Zoja C, Rossi EC (1987) Prostacyclin in thrombotic microangiopathy. Semin Hematol 24:110?118","journal-title":"Semin Hematol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/adc.58.9.703","volume":"58","author":"M Levin","year":"1983","unstructured":"Levin M, Elkon KB, Nokes TJC, Buckle AM, Dillon MJ, Hardisty RM, Barratt TM (1983) Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome. Arch Dis Child 58:703?708","journal-title":"Arch Dis Child"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-3476(87)80344-X","volume":"111","author":"N Schlegel","year":"1987","unstructured":"Schlegel N, Maclouf J, Loirat C, Drouet L, Marotte R, Scarabin PY, Mathieu H (1987) Absence of plasma prostacyclin stimulating activity deficiency in hemolytic uremic syndrome. J Pediatr 111: 71?77","journal-title":"J Pediatr"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ki.1990.96","volume":"37","author":"B T\u00f6nshoff","year":"1990","unstructured":"T\u00f6nshoff B, Momper R, K\u00fchl PG, Schweer H, Sch\u00e4rer K, Seyberth HW (1990) Increased thromboxane biosynthesis in childhood hemolytic uremic syndrome. Kidney Int 37:1134?1141","journal-title":"Kidney Int"},{"key":"CR24","first-page":"43","volume":"18","author":"G Defreyn","year":"1982","unstructured":"Defreyn G, Proesmans W, Machin SJ, Lemmens F, Vermylen J (1982) Abnormal prostacyclin metabolism in the hemolytic uremic syndrome: equivocal effect of prostacyclin infusions. Clin Nephrol 18:43?49","journal-title":"Clin Nephrol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/ki.1986.210","volume":"30","author":"KF Badr","year":"1986","unstructured":"Badr KF, Kelly VE, Remke HG, Brenner BM (1986) Roles for thromboxane A2 and leukotrienes in endotoxin-induced acute renal failure. Kidney Int 30:474?480","journal-title":"Kidney Int"},{"key":"CR26","first-page":"645","volume":"21","author":"B T\u00f6nshoff","year":"1991","unstructured":"T\u00f6nshoff B, Momper R, Schweer H, Sch\u00e4rer K, Seyberth HW (1991) Increased formation of thromboxane A2 and prostacyclin in anaphylactoid purpura. Adv Prostaglandin Thromboxane Leukotriene Res 21:645?649","journal-title":"Adv Prostaglandin Thromboxane Leukotriene Res"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/ki.1989.82","volume":"35","author":"EA Lianos","year":"1989","unstructured":"Lianos EA (1989) Eicosanoids and the modulation of glomerular immune injury. Kidney Int 35:985?992","journal-title":"Kidney Int"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1172\/JCI111100","volume":"72","author":"EA Lianos","year":"1983","unstructured":"Lianos EA, Andres GA, Dunn MJ (1983) Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic nephritis. J Clin Invest 72:1439?1448","journal-title":"J Clin Invest"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI109987","volume":"66","author":"DJ Salant","year":"1980","unstructured":"Salant DJ, Belak S, Madaio MP, Couser WG (1980) A new role for complement in experimental membranous nephropathy in rats. J Clin Invest 66:1339?1350","journal-title":"J Clin Invest"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ki.1977.25","volume":"11","author":"WG Couser","year":"1977","unstructured":"Couser WG, Stilmant MM, Jermanovich NB (1977) Complement-independent nephrotoxic nephritis in the guinea pig. Kidney Int 11:170?170","journal-title":"Kidney Int"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/ki.1985.175","volume":"28","author":"K Kaizu","year":"1985","unstructured":"Kaizu K, March D, Zipser R, Glassock RJ (1985) Role of prostaglandin and angiotensin II in experimental glomerulonephritis. Kidney Int 28:629?635","journal-title":"Kidney Int"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ki.1987.138","volume":"31","author":"T Bertani","year":"1987","unstructured":"Bertani T, Livio M, Macconi D, Mongi M, Bisogno G, Patrono C, Remuzzi G (1987) Platelet activating factor as a mediator of injury in nephrotoxic nephritis. Kindney Int 31:1248?1256","journal-title":"Kindney Int"},{"key":"CR33","first-page":"57","volume":"5","author":"JL Barnes","year":"1985","unstructured":"Barnes JL, Venkatachalam M (1985) The role of platelets and polycationic mediators in glomerular vascular injury. Semin Nephrol 5:57?67","journal-title":"Semin Nephrol"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1172\/JCI111703","volume":"75","author":"G Remuzzi","year":"1985","unstructured":"Remuzzi G, Imberti L, Rossini M, Morelli C, Carmanotti C, Cattaneo GM, Bertani T (1985) Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis. J Clin Invest 75:94?101","journal-title":"J Clin Invest"},{"key":"CR35","first-page":"672","volume":"233","author":"JE Stork","year":"1985","unstructured":"Stork JE, Dunn MJ (1985) Hemodynamic roles of thromboxane A2 and prostaglandin E2 in glomerulonephritis. J Pharmacol Exp Ther 233:672?678","journal-title":"J Pharmacol Exp Ther"},{"key":"CR36","first-page":"45","volume":"128","author":"AV Cybulski","year":"1987","unstructured":"Cybulski AV, Lieberthal W, Quigg RJ, Rennke HG, Salant DJ (1987) A role of thromboxane in complement-mediated glomerular injury. Am J Pathol 128:45?51","journal-title":"Am J Pathol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ki.1987.118","volume":"31","author":"RAK Stahl","year":"1987","unstructured":"Stahl RAK, Adler S, Baker PJ, Chen YP, Pritzl PM, Couser WG (1987) Enhanced glomerular prostaglandin formation in experimental membranous nephropathy. Kidney Int 31:1126?1131","journal-title":"Kidney Int"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0140-6736(90)92088-Y","volume":"336","author":"A Benigni","year":"1990","unstructured":"Benigni A, Rizzoni G, Antolini A, Piccinelli A, Remuzzi G (1990) Preliminary report: renal thromboxane A2 synthesis in children with frequent relapsing nephrotic syndrome. Lancet 336:533?534","journal-title":"Lancet"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000184369","volume":"46","author":"T Niwa","year":"1987","unstructured":"Niwa T, Maeda K, Shibata M (1987) Urinary prostaglandins and thromboxane in patients with chronic glomerulonephritis. Nephron 46:281?287","journal-title":"Nephron"},{"key":"CR40","first-page":"276","volume":"30","author":"T Niwa","year":"1988","unstructured":"Niwa T, Maeda K, Shibata M, Yamada K (1988) Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome. Clin Nephrol 30:276?281","journal-title":"Clin Nephrol"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1056\/NEJM198405313102203","volume":"310","author":"JV Donadio","year":"1984","unstructured":"Donadio JV, Anderson CF, Mitchell JC, Holley KE, Ilstrup DM, Fuster V, Chesero JH (1984) Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy. N Engl J Med 310:1421?1426","journal-title":"N Engl J Med"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1172\/JCI112053","volume":"76","author":"C Patrono","year":"1985","unstructured":"Patrono C, Ciabattoni G, Remuzzi G, Gotti E, Bombardieri S, Di Munno O Tartarelli G, Cinotti GA, Simonetti BM, Pierucci A (1985) Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. J Clin Invest 76:1011?1018","journal-title":"J Clin Invest"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198902163200703","volume":"320","author":"A Pierucci","year":"1989","unstructured":"Pierucci A, Simonetti BM, Pecci G, Mavrikakis G, Feriozzi S, Cinotti GA, Patrignani P, Ciabattoni G, Patrono C (1989) Improvement of renal function with selective thromboxane antagonism in lupus nephritis. N Engl J Med 320:421?425","journal-title":"N Engl J Med"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1172\/JCI111822","volume":"75","author":"TM Coffmann","year":"1985","unstructured":"Coffmann TM, Yarger WE, Klotman PE (1985) Functional role of thromboxane production by acutely rejecting renal allografts in rats. J Clin Invest 75:1242?1248","journal-title":"J Clin Invest"},{"key":"CR45","first-page":"3633","volume":"19","author":"ML Foegh","year":"1987","unstructured":"Foegh ML, Lim K, Alijani MR, Helfrich GB, Ramwell PW (1987) Thromboxane and inflammatory cell infiltration of the allograft of renal transplant patients. Transplant Proc 19:3633?3636","journal-title":"Transplant Proc"},{"key":"CR46","doi-asserted-by":"crossref","first-page":"C58","DOI":"10.1007\/BF00858645","volume":"4","author":"B T\u00f6nshoff","year":"1990","unstructured":"T\u00f6nshoff B, Busch C, Schweer H, Sch\u00e4rer K, Seyberth HW (1990) Increased biosynthesis of vasoactive prostanoids in acute renal allograft rejection (abstract). Pediatr Nephrol 4:C58","journal-title":"Pediatr Nephrol"},{"key":"CR47","first-page":"424","volume":"20","author":"ML Foegh","year":"1988","unstructured":"Foegh ML, Lim K, Douglas F, Turk J, Helfrich GB, Taher SA, Alijani MR (1988) Differential effect of CGS 13080, a thromboxane synthese inhibitor, in suppressing serum and urine immunoreactive thromboxane B2 in kidney transplant patients. Transplant Proc 20:424?427","journal-title":"Transplant Proc"},{"key":"CR48","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1056\/NEJM199004263221703","volume":"322","author":"M Moran","year":"1990","unstructured":"Moran M, Mozes MF, Maddux MS, Veremis S, Bartkus C, Ketel B, Pollak R, Wallemark C, Jonasson O (1990) Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal transplant recipients treated with cyclosporine and prednisone. N Engl J Med 322:1183?1188","journal-title":"N Engl J Med"},{"key":"CR49","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0090-1229(81)90208-7","volume":"21","author":"VE Kelley","year":"1981","unstructured":"Kelley VE, Winklestein A, Izui S, Dixon FJ (1981) Prostaglandin E1 inhibits T-cell proliferation and renal disease in MRL\/1 mice. Clin Immunol Immunopathol 21:190?203","journal-title":"Clin Immunol Immunopathol"},{"key":"CR50","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0090-1229(83)90169-1","volume":"26","author":"KR McLeish","year":"1983","unstructured":"McLeish KR, Gohara AF, Stelzer GT, Wallace JH (1983) Treatment of murine immune-complex glomerulonephritis with prostaglandin E2: dose response of immune complex deposition, antibody synthesis and glomerular damage. Clin Immunol Immunopathol 26: 18?23","journal-title":"Clin Immunol Immunopathol"},{"key":"CR51","first-page":"240","volume":"108","author":"SL Kunkel","year":"1982","unstructured":"Kunkel SL, Zanetti M, Sapin C (1982) Suppression of nephrotoxic serum nephritis in rats by prostaglandin E1. Am J Pathol 108: 240?245","journal-title":"Am J Pathol"},{"issue":"Suppl 1","key":"CR52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2165\/00003495-198700331-00009","volume":"33","author":"M Dunn","year":"1987","unstructured":"Dunn M (1987) The role of arachidonic acid metabolites in renal homeostasis. Drugs 33 [Suppl 1]:56?66","journal-title":"Drugs"},{"issue":"Suppl 1","key":"CR53","first-page":"13","volume":"13","author":"TH Hostetter","year":"1989","unstructured":"Hostetter TH (1989) Antihypertensive therapy in diabetes. Am J Kidney Dis 13 [Suppl 1]:13?16","journal-title":"Am J Kidney Dis"},{"key":"CR54","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ki.1981.33","volume":"19","author":"TH Hostetter","year":"1981","unstructured":"Hostetter TH, Troy IL, Brenner BM (1981) Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19:410?415","journal-title":"Kidney Int"},{"key":"CR55","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-110-10-795","volume":"110","author":"RH Noth","year":"1989","unstructured":"Noth RH, Krolewski AS, Kaysen AG, Meyer TW, Schambelan M (1989) Diabetic nephropathy: hemodynamic basis and implications for disease management. Ann Intern Med 110:795?813","journal-title":"Ann Intern Med"},{"key":"CR56","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00274575","volume":"30","author":"E Hommel","year":"1987","unstructured":"Hommel E, Mathiesen E, Arnold-Larson S, Edsberg B, Olson UB, Parving HH (1987) Effects of indomethacin on kidney function in type 1 (insulin-dependent) diabetic patients with nephropathy. Diabetologia 30:78?81","journal-title":"Diabetologia"},{"key":"CR57","first-page":"300","volume":"110","author":"DI Moel","year":"1987","unstructured":"Moel DI, Safirstein RL, McEvoy RC, Hsueh W (1987) Effects of aspirin on experimental diabetic nephropathy. J Lab Clin Med 110: 300?307","journal-title":"J Lab Clin Med"},{"key":"CR58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1464-5491.1989.tb01150.x","volume":"6","author":"GC Viberti","year":"1989","unstructured":"Viberti GC, Begnini A, Bognetti E, Remuzzi G, Wieseman MJ (1989) Glomerular hypoperfusion and urinary prostaglandins in type 1 diabetes mellitus. Diabetic Med 6:219?223","journal-title":"Diabetic Med"},{"key":"CR59","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1172\/JCI111714","volume":"75","author":"M Schambelan","year":"1985","unstructured":"Schambelan M, Blake S, Sraer J, Nivez M, Wahbe F (1985) Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest 75:404?412","journal-title":"J Clin Invest"},{"key":"CR60","first-page":"326","volume":"25","author":"A Chaudhari","year":"1984","unstructured":"Chaudhari A, Kirschenbaum MA (1984) Effect of experimental diabetes mellitus on eicosanoid biosynthesis in isolated rat glomeruli (abstract). Kidney Int 25:326?326","journal-title":"Kidney Int"},{"key":"CR61","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ki.1986.26","volume":"29","author":"P Koch-Jensen","year":"1986","unstructured":"Koch-Jensen P, Kenneth S, Blaehr H, Christiansen JS, Parving H (1986) Effect of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int 29:490?495","journal-title":"Kidney Int"},{"key":"CR62","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ki.1988.117","volume":"33","author":"RT Kopecky","year":"1988","unstructured":"Kopecky RT, Schroeder RT (1988) Glomerular prostaglandin production in diabetic rats with renovascular hypertension. Kidney Int 33:1100?1106","journal-title":"Kidney Int"},{"key":"CR63","first-page":"79","volume":"50","author":"FC Bartter","year":"1982","unstructured":"Bartter FC, Rodriguez JA (1982) Bartter's syndrome. Ergeb Inn Med Kinderheilkd 50:79?103","journal-title":"Ergeb Inn Med Kinderheilkd"},{"key":"CR64","first-page":"560","volume":"94","author":"P Rosenbaum","year":"1957","unstructured":"Rosenbaum P, Hughes M (1957) Persistent, probably congenital hypokalemic metabolic alkalosis with hyaline degeneration of renal tubules and normal urinary aldosterone. Am J Dis Child 94:560","journal-title":"Am J Dis Child"},{"key":"CR65","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0002-9343(62)90214-0","volume":"33","author":"FC Bartter","year":"1962","unstructured":"Bartter FC, Pronove P, Gill JR, McCardle RC (1962) Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. Am J Med 33:811?828","journal-title":"Am J Med"},{"key":"CR66","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/0002-9343(78)90794-5","volume":"65","author":"JR Gill","year":"1978","unstructured":"Gill JR, Bartter FC (1978) Evidence for a prostaglandin-independent defect in chloride reabsorption in the loop of Henle as a proximal cause of Bartter's syndrome. Am J Med 65:766?772","journal-title":"Am J Med"},{"key":"CR67","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0002-9343(76)90029-2","volume":"61","author":"JR Gill","year":"1976","unstructured":"Gill JR, Fr\u00f6lich JC, Bowden RE, Taylor AA, Keiser HR, Seyberth HW, Oates JA, Bartter FC (1976) Bartter's syndrome: a disorder characterized by high urinary prostaglandins and a dependency of hyperreninemia on prostaglandin synthesis. Am J Med 61:43?51","journal-title":"Am J Med"},{"key":"CR68","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF00849259","volume":"1","author":"HW Seyberth","year":"1987","unstructured":"Seyberth HW, K\u00f6niger SJ, Rascher W, K\u00fchl PG, Schweer H (1987) Role of prostaglandins in hyperprostaglandin E syndrome and in selected renal tubular disorders. Pediatr Nephrol 1:491?497","journal-title":"Pediatr Nephrol"},{"key":"CR69","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0002-9343(76)90892-5","volume":"60","author":"MP Fichmann","year":"1976","unstructured":"Fichmann MP, Telfer N, Zia P, Speckart P, Golub M, Rude R (1976) Role of prostaglandins in the pathogenesis of Bartter's syndrom. Am J Med 60:785?797","journal-title":"Am J Med"},{"key":"CR70","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ki.1976.33","volume":"9","author":"R Verberchmoes","year":"1976","unstructured":"Verberchmoes R, Van Damme B, Clement J, Amery A, Nichielsen P (1976) Bartter's syndrome with hyperplasia of renomedullary cells: successful treatment with indomethacin. Kidney Int 9:302?307","journal-title":"Kidney Int"},{"key":"CR71","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0140-6736(76)90669-3","volume":"II","author":"L Norby","year":"1976","unstructured":"Norby L, Flamenbaum W, Lentz R, Ramwell P (1976) Prostaglandins and aspirin therapy in Bartter's syndrom. Lancet II:604?606","journal-title":"Lancet"},{"key":"CR72","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jama.1978.03280290037017","volume":"239","author":"RE Bowden","year":"1978","unstructured":"Bowden RE, Gill JR, Radford N, Taylor AA, Keiser HR (1978) Prostaglandin synthetase inhibitors in Bartter's syndrom. JAMA 239:117?121","journal-title":"JAMA"},{"key":"CR73","first-page":"F515","volume":"235","author":"FS Wright","year":"1978","unstructured":"Wright FS, Giebisch G (1978) Renal potassium transport: contributions of individual nephron segments and populations. Am J Physiol 235:F515-F527","journal-title":"Am J Physiol"},{"key":"CR74","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000167433","volume":"7","author":"L Milani","year":"1987","unstructured":"Milani L, Pessina AC, Macca F, Pauletto P, Gatta A (1987) Does defective chloride reabsorption at the loop of Henle play a major role in the pathogenesis of Bartter's syndrome? Am J Nephrol 7:65?68","journal-title":"Am J Nephrol"},{"key":"CR75","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000184329","volume":"46","author":"A Hornych","year":"1987","unstructured":"Hornych A, Huet de Barohez Y, Bariety J, Branca GF, Vigeral P, Girard JF, Kazatchkine M, De Gennes JL, Truffert J, Bocquet L (1987) Bartter's syndrome with normal chloride reabsorption during indomethacin treatment. Nephron 46:137?143","journal-title":"Nephron"},{"key":"CR76","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1172\/JCI108733","volume":"52","author":"JB Stokes","year":"1977","unstructured":"Stokes JB, Kokko JP (1977) Inhibition of sodium transport by prostaglandin E2 across the isolated perfused rabbit collection tube. J Clin Invest 52:1099?1104","journal-title":"J Clin Invest"},{"key":"CR77","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1172\/JCI109487","volume":"64","author":"JB Stokes","year":"1979","unstructured":"Stokes JB (1979) Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of Henle. J Clin Invest 64: 495?499","journal-title":"J Clin Invest"},{"key":"CR78","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0022-3476(85)80395-4","volume":"107","author":"HW Seyberth","year":"1985","unstructured":"Seyberth HW, Rascher W, Schweer H, K\u00fchl PG, Mehls O, Sch\u00e4rer K (1985) Congenital hypokalemia with hypercalciuria in preterm infants: a hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr 107:694?701","journal-title":"J Pediatr"},{"key":"CR79","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0022-3476(89)80838-8","volume":"115","author":"C Restrepo de Rovetto","year":"1989","unstructured":"Restrepo de Rovetto C, Welch TR, Hug G, Clark KE, Bergstrom W (1989) Hypercalciuria with Bartter syndrome: evidence for an abnormality of vitamin D metabolism. J Pediatr 115:397?404","journal-title":"J Pediatr"},{"key":"CR80","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/BF00862592","volume":"2","author":"W Proesmans","year":"1988","unstructured":"Proesmans W, Massa G, Vanderschueren-Lodewyckx M (1988) Growth from birth to adulthood in a patient with the neonatal form of Bartter syndrome. Pediatr Nephrol 2:205?209","journal-title":"Pediatr Nephrol"},{"key":"CR81","first-page":"144","volume":"2","author":"A Fanconi","year":"1971","unstructured":"Fanconi A, Schachemann G, N\u00fcssli R, Prader A (1971) Chronic hyperkalaemia with growth retardation, normotensive hyperreninhyperaldosteronism (?Bartter's syndrome?), and hypercalciuria. Helv Paediatr Acta 2:144?163","journal-title":"Helv Paediatr Acta"},{"key":"CR82","first-page":"286","volume":"10","author":"DA McCredie","year":"1974","unstructured":"McCredie DA, Rotenberg E, Williams AL (1974) Hypercalciuria in potassium-losing nephropathy: a variant of Bartter's syndrome. Aust Paediatr J 10:286?295","journal-title":"Aust Paediatr J"},{"key":"CR83","first-page":"429","volume":"191","author":"JM Dillon","year":"1979","unstructured":"Dillon JM, Shah V, Mitchell MD (1979) Bartter's syndrome: 10 cases in childhood. Q J Med 191:429?446","journal-title":"Q J Med"},{"key":"CR84","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1651-2227.1984.tb17793.x","volume":"73","author":"A Ohlsson","year":"1984","unstructured":"Ohlsson A, Sieck U, Cumming W, Akhtar M, Serenius F (1984) A variant of Bartter's syndrome. Acta Paediatr Scand 73:868?874","journal-title":"Acta Paediatr Scand"},{"key":"CR85","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ki.1984.152","volume":"26","author":"M Houser","year":"1984","unstructured":"Houser M, Zimmerman B, Smith C, Sinaiko A, Fish A (1984) idiopathic hypercalciuria associated with hyperreninemia and high urinary prostaglandin E. Kidney Int 26:176?182","journal-title":"Kidney Int"},{"key":"CR86","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/BF00750580","volume":"412","author":"R Taugner","year":"1988","unstructured":"Taugner R, Waldherr R, Seyberth HW, Erd\u00f6s EG, Menard J, Schneider D (1988) The juxtaglomerular apparatus in Bartter's syndrome and related tubulopathies. An immunocytochemical and electron microscopic study. Virchows Arch [A] 412:459?470","journal-title":"Virchows Arch [A]"},{"key":"CR87","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2214\/ajr.152.6.1251","volume":"152","author":"J Matsumoto","year":"1989","unstructured":"Matsumoto J, Han BK, Restrepo de Rovetto C, Welch TR (1989) Hypercalciuric Bartter syndrome: resolution of nephrocalcinosis with indomethacin. AJR 152:1251?1253","journal-title":"AJR"},{"key":"CR88","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ki.1973.133","volume":"4","author":"EG Schmider","year":"1973","unstructured":"Schmider EG, Strandhoy JW, Willis LR, Knox FG (1973) Relationship between proximal reabsorption and excretion of calcium, magnesium, and phsophate. Kidney Int 4:369?376","journal-title":"Kidney Int"},{"key":"CR89","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0022-5347(17)52130-8","volume":"129","author":"AC Buck","year":"1983","unstructured":"Buck AC, Lote CJ, Sampson WF (1983) The influence of renal prostaglandins on urinary calcium excretion in idiopathic urolithiasis. J Urol 129:421?426","journal-title":"J Urol"},{"key":"CR90","first-page":"295","volume":"230","author":"RJ Roman","year":"1984","unstructured":"Roman RJ, Skelton M, Lechene C (1984) Prostaglandin-vasopressin interactions on the renal handling of calcium and magnesium. J Pharmacol Exp Ther 230:295?301","journal-title":"J Pharmacol Exp Ther"},{"key":"CR91","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0022-5347(17)42517-1","volume":"139","author":"H Hirayama","year":"1988","unstructured":"Hirayama H, Ikegami K, Shimomura T, Soejima H, Yamamoto T (1988) The possible role of prostaglandin E2 in urinary stone formation. J Urol 139:549?551","journal-title":"J Urol"},{"key":"CR92","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF02555148","volume":"43","author":"P Filipponi","year":"1988","unstructured":"Filipponi P, Mannarelli C, Pacifici R, Grossi E, Moretti I, Tini S, Carloni C, Blass A, Morucci P, Hruska KA, Avioli LV (1988) Evidence for a prostaglandin-mediated bone resorptive mechanism in subjects with fasting hypercalciuria. Calcif Tissue Int 43:61?66","journal-title":"Calcif Tissue Int"},{"key":"CR93","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/cs0750581","volume":"75","author":"C Henriquez-La Roche","year":"1988","unstructured":"Henriquez-La Roche C, Rodriguez-Iturbe B, Herrera J, Parra G (1988) Increased excretion of prostaglandin E in patients with idiopathic hypercalciuria. Clin Sci 75:581?587","journal-title":"Clin Sci"},{"key":"CR94","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1152\/ajplegacy.1974.227.4.801","volume":"227","author":"MA Kirschenbaum","year":"1977","unstructured":"Kirschenbaum MA, White N, Stein HJ (1977) Redistribution of renal cortical blood flow during inhibition of prostaglandin synthesis. Am J Physiol 227:801?805","journal-title":"Am J Physiol"},{"issue":"Suppl 1","key":"CR95","first-page":"165","volume":"34?35","author":"HD Itskowitz","year":"1974","unstructured":"Itskowitz HD, McGill JC (1974) Hormonal regulation of renal circulation. Circ Res 34?35 [Suppl 1]:165?173","journal-title":"Circ Res"},{"key":"CR96","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.2042-7158.1983.tb02938.x","volume":"35","author":"J Haylor","year":"1983","unstructured":"Haylor J, Lot CJ (1983) The influence of prostaglandin E2 and indomethacin on the renal corticomedullary solute gradient in the rat. J Pharmacol 35:299?305","journal-title":"J Pharmacol"},{"key":"CR97","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0022-3476(80)80211-3","volume":"97","author":"M Usberti","year":"1980","unstructured":"Usberti M, Dechaux M, Guillot M, Seligman R, Parlovitch H, Loirat C, Sachs C, Broyer M (1980) Renal prostaglandin E2 in nephrogenic diabetes insipidus: effect of prostaglandin synthesis by indomethacin. J Pediatr 97:476?478","journal-title":"J Pediatr"},{"key":"CR98","first-page":"48","volume":"1","author":"Y Blachar","year":"1980","unstructured":"Blachar Y, Zadik Z, Shemesh M, Kaplan BS, Levin S (1980) The effect of prostaglandin synthesis on free water clearance and osmolar clearances in patients with hereditary nephrogenic diabetes insipidus. Int J Pediatr Nephrol 1:48?52","journal-title":"Int J Pediatr Nephrol"},{"key":"CR99","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/BF00849258","volume":"1","author":"W Rascher","year":"1987","unstructured":"Rascher W, Rosendahl W, Henrichs IA, Maier R, Seyberth HW (1987) Congenital nephrogenic diabetes insipidus ? vasopressin and prostaglandins in response to treatment with hydrochlorothiazide and indomethacin. Pediatr Nephrol 1:458?490","journal-title":"Pediatr Nephrol"},{"key":"CR100","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ki.1983.36","volume":"23","author":"S Klahr","year":"1983","unstructured":"Klahr S (1983) Pathophysiology of obstructive nephropathy. Kidney Int 23:414?426","journal-title":"Kidney Int"},{"key":"CR101","first-page":"1","volume":"205","author":"AR Morrison","year":"1987","unstructured":"Morrison AR, Nishikawa K, Needleman P (1987) Thromboxane A2 biosynthesis in the ureter obstructed isolated perfused kidney of the rabbit. J Pharmacol Exp Ther 205:1?8","journal-title":"J Pharmacol Exp Ther"},{"key":"CR102","first-page":"F282","volume":"250","author":"PE Klotman","year":"1986","unstructured":"Klotman PE, Smith SR, Volpp BD, Coffman TM, Yarger WE (1986) Thromboxane synthetase inhibition improves function of hydronephrotic rat kidneys. Am J Physiol 250:F282-F287","journal-title":"Am J Physiol"},{"key":"CR103","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/ki.1985.97","volume":"27","author":"P Balint","year":"1985","unstructured":"Balint P, Laszlo K (1985) Effect of imidazole and indomethacin on hemodynamics of the obstructed canine kidney. Kidney Int 27: 892?897","journal-title":"Kidney Int"},{"key":"CR104","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00256014","volume":"16","author":"J Frokiaer","year":"1988","unstructured":"Frokiaer J, Jensen T, Husted SE, Mortensen J, Djurhuus JC (1988) Renal blood flow and pelvic pressure after four weeks of total urinary tract obstruction in the pig. Urol Res 16:167?171","journal-title":"Urol Res"},{"key":"CR105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1042\/cs0730395","volume":"73","author":"S Torikai","year":"1987","unstructured":"Torikai S (1987) Tubular prostaglandin E2 production and its role in urinary hypotonicity after release of ureteral occlusion in the rat. Clin Sci 73:395?399","journal-title":"Clin Sci"},{"key":"CR106","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0952-3278(88)90108-1","volume":"31","author":"Y Fradet","year":"1988","unstructured":"Fradet Y, Lebel M, Grose JH, Talbot J, Charrois R (1988) Renal prostaglandins in postobstructive diuresis. Comparative study of unilateral and bilateral obstruction in conscious dogs. Prostaglandins Leuko Essent Fatty Acids 31:123?129","journal-title":"Prostaglandins Leuko Essent Fatty Acids"},{"key":"CR107","first-page":"F281","volume":"27","author":"SI Himmelstein","year":"1990","unstructured":"Himmelstein SI, Cofman TM, Yarger WE, Kotman PE (1990) Atrial natriuretic peptide-induced changes in renal prostacyclin production in ureteral obstruction. Am J Physiol 27:F281-F286","journal-title":"Am J Physiol"},{"key":"CR108","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/01.RES.50.4.486","volume":"50","author":"A Kawasaki","year":"1982","unstructured":"Kawasaki A, Needleman P (1982) Contribution of thromboxane to renal resistance changes in the isolated perfused hydronephrotic rabbit kidney. Circ Res 50:486?490","journal-title":"Circ Res"},{"key":"CR109","first-page":"10","volume":"235","author":"SM Weisman","year":"1985","unstructured":"Weisman SM, Felsen D, Vaughan ED (1985) Platelet-activating factor is a potent stimulus for renal prostaglandin synthesis: possible significance in unilateral ureteral obstruction. J Pharmacol Exp Ther 235:10?15","journal-title":"J Pharmacol Exp Ther"},{"key":"CR110","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1161\/01.RES.61.4.514","volume":"61","author":"CR Albrightson","year":"1987","unstructured":"Albrightson CR, Evers AS, Griffin AC, Needleman P (1987) Effect of endogenously produced leukotrienes and thromboxane on renal vascular resistance in rabbit hydronephrosis. Circ Res 61:514?522","journal-title":"Circ Res"},{"key":"CR111","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ki.1984.127","volume":"26","author":"JB Lefkowith","year":"1984","unstructured":"Lefkowith JB, Okegawa T, DeSchryver-Kecskemeti K, Needleman P (1984) Macrophage-dependent arachidonate metabolism in hydronephrosis. Kidney Int 26:10?17","journal-title":"Kidney Int"},{"key":"CR112","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/ki.1988.207","volume":"34","author":"GF Schreiner","year":"1988","unstructured":"Schreiner GF, Harris KPG, Purkerson ML, Klahr S (1988) Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int 34:187?193","journal-title":"Kidney Int"},{"key":"CR113","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1203\/00006450-199001000-00025","volume":"27","author":"PG K\u00fchl","year":"1990","unstructured":"K\u00fchl PG, Sch\u00f6nig G, Schweer H, Seyberth HW (1990) Increased renal biosynthesis of prostaglandin E2 and thromboxane B2 in human congenital obstructive uropathy. Pediatr Res 27:103?107","journal-title":"Pediatr Res"},{"key":"CR114","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/S0022-3476(87)80398-0","volume":"110","author":"G Marra","year":"1987","unstructured":"Marra G, Goj V, Appiani AC, Dell Agnola CA, Tirelli SA, Tadini B, Nicolini U, Cavanna G, Assael BM (1987) Persistent tubular resistance to aldosterone in infants with congenital hydronephrosis corrected neonatally. J Pediatr 110:868?872","journal-title":"J Pediatr"},{"key":"CR115","first-page":"232","volume-title":"Pediatric nephrology","author":"HW Seyberth","year":"1987","unstructured":"Seyberth HW (1987) Prostaglandins (arachidonate cascade). In: Holliday MA, Barrat TM, Vernier R (eds) Pediatric nephrology. Williams and Wilkins, Baltimore, pp 232?241"},{"key":"CR116","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0022-3476(83)80736-7","volume":"103","author":"HW Seyberth","year":"1983","unstructured":"Seyberth HW, Rascher W, Hackenthal R, Wille L (1983) Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic ductus arteriosus. J Pediatr 103:979?984","journal-title":"J Pediatr"},{"key":"CR117","doi-asserted-by":"crossref","first-page":"336","DOI":"10.7326\/0003-4819-89-3-336","volume":"89","author":"RP Kimberly","year":"1978","unstructured":"Kimberly RP, Gill JR, Bowden RE, Keiser HR, Plotz PH (1978) Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus. Ann Intern Med 89:336?341","journal-title":"Ann Intern Med"},{"key":"CR118","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ki.1986.253","volume":"30","author":"RD Toto","year":"1986","unstructured":"Toto RD, Anderson SA, Brown-Cartwright D, Kokko JP, Brater DC (1986) Effects of acute and chronic dosing of NSAIDs in patients with renal insufficiency. Kidney Int 30:760?768","journal-title":"Kidney Int"},{"key":"CR119","doi-asserted-by":"crossref","first-page":"568","DOI":"10.7326\/0003-4819-112-8-568","volume":"112","author":"A Whelton","year":"1990","unstructured":"Whelton A, Sout RL, Slilman PS, Klassen DK (1990) Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure. Ann Intern Med 112:568?576","journal-title":"Ann Intern Med"},{"key":"CR120","first-page":"449","volume":"231","author":"MJS Miller","year":"1984","unstructured":"Miller MJS, Bednar MM, McGiff JC (1984) Renal metabolism of sulindac: functional implications. J Pharmacol Exp Ther 231: 449?456","journal-title":"J Pharmacol Exp Ther"},{"key":"CR121","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/clpt.1987.194","volume":"42","author":"MH Skinner","year":"1987","unstructured":"Skinner MH, Mutterperl R, Zeitz HJ (1987) Sulindac inhibits bumetanide-induced sodium and water excretion. Clin Pharmacol Ther 42:542?546","journal-title":"Clin Pharmacol Ther"},{"key":"CR122","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0952-3278(88)90167-6","volume":"31","author":"AA Grace","year":"1988","unstructured":"Grace AA (1988) Cyclosporine A nephrotoxicity ? the role of thromboxane A2. Prostaglandins Leukot Essent Fatty Acids 31: 157?164","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"CR123","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ki.1988.162","volume":"34","author":"A Benigni","year":"1988","unstructured":"Benigni A, Chiabrando C, Piccinelli A, Perico N, Gavinelli M, Furci L, Patino O, Abbate M, Bertani T, Remuzzi G (1988) Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporine nephrotoxicity. Kidney Int 34:164?174","journal-title":"Kidney Int"},{"key":"CR124","first-page":"663","volume":"20","author":"C Smeesters","year":"1988","unstructured":"Smeesters C, Chaland P, Giroux L, Moutquin JM, Etienne P, Douglas F, Corman J, St-Louis G, Daloze P (1988) Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor. Transplant Proc 20:663?669","journal-title":"Transplant Proc"},{"key":"CR125","doi-asserted-by":"crossref","first-page":"474","DOI":"10.7326\/0003-4819-103-3-474_2","volume":"103","author":"RAK Stahl","year":"1985","unstructured":"Stahl RAK, Kanz L, Kudelka S (1985) Cyclosporine and renal prostaglandin E2 production. Ann Intern Med 103:474?474","journal-title":"Ann Intern Med"},{"key":"CR126","first-page":"1","volume":"8","author":"RJ Flower","year":"1984","unstructured":"Flower RJ (1984) Macrocortin and the antiphospholipase proteins. Adv Inflamm Res 8:1?34","journal-title":"Adv Inflamm Res"},{"key":"CR127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-4731(88)90088-X","volume":"30","author":"A Naray-Fejes-Toth","year":"1988","unstructured":"Naray-Fejes-Toth A, Rosenkranz B, Fr\u00f6lich JC, Fejes-Toth G (1988) Glucocorticoid effect on arachidonic acid metabolism in vivo. J Steroid Biochem 30:1?6","journal-title":"J Steroid Biochem"},{"key":"CR128","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/bjc.1980.258","volume":"42","author":"HW Seyberth","year":"1980","unstructured":"Seyberth HW, Bonsch G, M\u00fcller H, Minne HW, Erlenmeier T, Strein K, Imbeck H, Mrongovius R (1980) Prostaglandin E production and hypercalcaemia in rats bearing the Walker carcinosarcoma. Br J Cancer 42:455?461","journal-title":"Br J Cancer"},{"key":"CR129","first-page":"572","volume":"11","author":"DA Dreiling","year":"1962","unstructured":"Dreiling DA, Biermann EL, Deboms AF, Elsbach P, Schwartz IL (1962) Effect of ACTH, hydrocortisone and glucagon on plasma nonesterified fatty acid concentration (NEFA) in normal subjects and in patients with liver disease. Metabolism 11:572?578","journal-title":"Metabolism"},{"key":"CR130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1042\/cs0590067","volume":"59","author":"HJ Kramer","year":"1980","unstructured":"Kramer HJ, D\u00fcsing R, Stinesbeck B, Prior W, B\u00e4cker A, Eden J, Kipnowski J, Gl\u00e4nzer K, Kr\u00fcck F (1980) Interaction of conventional and antikaliuretic diuretics with the renal prostaglandin system. Clin Sci 59:67?70","journal-title":"Clin Sci"},{"key":"CR131","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-2999(79)90217-6","volume":"60","author":"G Ciabattoni","year":"1979","unstructured":"Ciabattoni G, Pugliese F, Cinotti GA, Stirati G, Ronci R, Castrucci G, Pierucci A, Patrono C (1979) Characterization of furosemide-induced activation of the renal prostaglandin system. Eur J Pharmacol 60:181?187","journal-title":"Eur J Pharmacol"},{"key":"CR132","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJM198303313081303","volume":"308","author":"TP Green","year":"1983","unstructured":"Green TP, Thompson TR, Johnson DA, Lock JE (1983) Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome. N Engl J Med 308: 743?748","journal-title":"N Engl J Med"},{"key":"CR133","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0090-6980(78)90164-8","volume":"15","author":"B Scherer","year":"1978","unstructured":"Scherer B, Schnermann J, Sofroniev M, Weber PC (1978) Prostaglandin (PG) analysis in urine of humans and rats by different radioimmunoassays: effect on PG excretion by PG-synthetase inhibitors, laparatomy and furosemide. Prostaglandins 15:255?266","journal-title":"Prostaglandins"},{"key":"CR134","first-page":"F555","volume":"247","author":"S Katayama","year":"1984","unstructured":"Katayama S, Atallah AA, Stahl RAK, Bloch DL, Lee JB (1984) Mechanism of furosemide-induced natriuresis by direct stimulation of renal prostaglandin E2. Am J Physiol 247:F555-F561","journal-title":"Am J Physiol"},{"key":"CR135","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0022-3476(78)81182-2","volume":"93","author":"Z Friedman","year":"1978","unstructured":"Friedman Z, Demers LM, Marks KH, Uhrmann S, Maisels MJ (1978) Urinary excretion of prostaglandin E following the administration of furosemide and indomethacin to sick low-birth-weight infants. J Pediatr 93:512?515","journal-title":"J Pediatr"},{"key":"CR136","first-page":"F494","volume":"236","author":"RV Patak","year":"1979","unstructured":"Patak RV, Fadem ST, Rosenblatt SG, Lifschitz MD, Stein JH (1979) Diuretic-induced changes in renal blood flow and prostaglandin E excretion in the dog. Am J Physiol 236:F494-F500","journal-title":"Am J Physiol"},{"key":"CR137","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/cs0680159","volume":"68","author":"IG Mackay","year":"1985","unstructured":"Mackay IG, Nath K, Cumming AD, Muir AL, Watson ML (1985) Haemodynamic and endocrine responses of the kidney to frusemide in mild essential hypertension. Clin Sci 68:159?164","journal-title":"Clin Sci"},{"key":"CR138","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0090-6980(77)90265-9","volume":"14","author":"K Abe","year":"1977","unstructured":"Abe K, Yasujima M, Chiba S, Irokawa N, Ito T, Yoshinaga K (1977) Effect of furosemide on urinary excretion of prostaglandin E in normal volunteers and patients with essential hypertension. Prostaglandins 14:513?521","journal-title":"Prostaglandins"},{"key":"CR139","first-page":"25","volume":"10","author":"M Yoshida","year":"1978","unstructured":"Yoshida M, Suzuki-Kusaba M, Satoh S (1978) Participation of the prostaglandin system in furosemide-induced changes of renal function in anesthetized rats. Renal Physiol 10:25?32","journal-title":"Renal Physiol"},{"key":"CR140","first-page":"172","volume":"38","author":"A Dupont","year":"1988","unstructured":"Dupont A, Gerlo E, Niepen P, Lackeman G, Piepsz A (1988) Renal pharmacodynamic effects of torasemide and furosemide in normal man. Arzneimittelforschung 38:172?174","journal-title":"Arzneimittelforschung"},{"key":"CR141","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/01.HYP.4.5.634","volume":"4","author":"TW Wilson","year":"1982","unstructured":"Wilson TW, Loadholt CB, Privitera PJ, Halushka PV (1982) Furosemide increases urine 6-keto-prostaglandin-F1a. Hypertension 4:634?641","journal-title":"Hypertension"},{"key":"CR142","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/clpt.1986.84","volume":"39","author":"AS Nies","year":"1986","unstructured":"Nies AS (1986) Prostaglandins and the control of the circulation. Clin Pharmacol Ther 39:481?488","journal-title":"Clin Pharmacol Ther"},{"key":"CR143","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0090-6980(76)90115-5","volume":"12","author":"KJ Stone","year":"1976","unstructured":"Stone KJ, Hart M (1976) Inhibition of renal PGE2-9-ketoreductase by diuretics. Prostaglandins 12:197?207","journal-title":"Prostaglandins"},{"key":"CR144","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/0006-2952(76)90481-0","volume":"25","author":"JT Wright","year":"1976","unstructured":"Wright JT, Corder CN, Taylor R (1976) Studies on rat kidney 15-hydroxy-prostaglandin dehydrogenase. Biochem Pharmacol 25: 1669?1673","journal-title":"Biochem Pharmacol"},{"key":"CR145","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0090-6980(77)90028-4","volume":"13","author":"A Hassid","year":"1977","unstructured":"Hassid A, Levine L (1977) Multiple molecular forms of prostaglandin 15-hydroxydehydrogenase and 9-ketoreductase in chicken kidney. Prostaglandins 13:503?516","journal-title":"Prostaglandins"},{"key":"CR146","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0161-4630(81)90084-7","volume":"6","author":"JG Gerber","year":"1981","unstructured":"Gerber JG, Nies AS (1981) Interaction between furosemide-induced renal vasodilation and the prostaglandin system. Prostaglandins Med 6:135?145","journal-title":"Prostaglandins Med"},{"key":"CR147","first-page":"469","volume":"199","author":"MD Bailie","year":"1976","unstructured":"Bailie MD, Crosslan K, Hook JB (1976) Natriuretic effect of furosemide after inhibition of prostaglandin synthetase. J Pharmacol Exp Ther 199:469?476","journal-title":"J Pharmacol Exp Ther"},{"key":"CR148","first-page":"451","volume":"15","author":"JB Lee","year":"1985","unstructured":"Lee JB, Katayama S (1985) Direct stimulation of renal prostaglandin E2 by furosemide. Adv Prostaglandin Thromboxane Leukotriene Res 15:451?453","journal-title":"Adv Prostaglandin Thromboxane Leukotriene Res"},{"key":"CR149","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1542\/peds.70.3.360","volume":"70","author":"KG Hufnagle","year":"1982","unstructured":"Hufnagle KG, Khan SN, Penn D, Cacciarelli A, Willimas P (1982) Renal calcifications: a complication of long-term furosemide therapy in infants. Pediatrics 70:360?363","journal-title":"Pediatrics"},{"key":"CR150","first-page":"1157","volume":"137","author":"PS Venkataraman","year":"1983","unstructured":"Venkataraman PS, Han BK, Tsang RC, Daugherty CC (1983) Secondary hyperparathyroidism and bone disease in infants receiving long-term furosemide therapy. Am J Dis Child 137:1157?1161","journal-title":"Am J Dis Child"},{"key":"CR151","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1172\/JCI109788","volume":"65","author":"SL Swartz","year":"1980","unstructured":"Swartz SL, Williams GH, Hollenberg NK, Levine L, Dluhy RG, Moore TJ (1980) Captopril induced changes in prostaglandin production: relationship to vascular responses in normal man. J Clin Invest 65:1257?1264","journal-title":"J Clin Invest"},{"key":"CR152","first-page":"F358","volume":"254","author":"E Podjarny","year":"1988","unstructured":"Podjarny E, Rathaus A, Pomeranz J, Shapira J, Magen H, Kariv N, Bernheim J (1988) Prostanoids in renal failure induced by converting enzyme inhibition in sodium-depleted rats. Am J Physiol 254: F358-F363","journal-title":"Am J Physiol"},{"key":"CR153","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.HYP.3.2.168","volume":"3","author":"TJ Moore","year":"1981","unstructured":"Moore TJ, Crantz FR, Hollenberg NK, Koletsky RJ, Leboff MS, Swartz SL, Levine L, Podolsky S, Dluhy RG, Williams GH (1981) Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension. Hypertension 3:168?173","journal-title":"Hypertension"},{"key":"CR154","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0041-008X(89)90131-2","volume":"98","author":"MJ Fettman","year":"1989","unstructured":"Fettman MJ, Wilke WL (1989) Captopril or prostaglandin E1 ameliorate adverse renal hemodynamic effects of indomethacin in uninephrectomized rats. Toxicol Appl Pharmacol 98:31?38","journal-title":"Toxicol Appl Pharmacol"},{"key":"CR155","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.HYP.11.2.147","volume":"11","author":"K Kudo","year":"1989","unstructured":"Kudo K, Abe K, Chiba S, Sato M, Yasujima M, Kohzuki M, Omata K, Tanno M, Tsunoda K, Yoshinaga K (1989) Role of thromboxane A2 in the hypertensive effect of captopril in essential hypertension. Hypertension 11:147?152","journal-title":"Hypertension"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00856660.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00856660\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00856660","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T03:06:12Z","timestamp":1682910372000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00856660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991]]},"references-count":155,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1991]]}},"alternative-id":["BF00856660"],"URL":"https:\/\/doi.org\/10.1007\/bf00856660","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991]]}}}